These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32141426)

  • 21. Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing.
    Smolen JS; van der Heijde DM; Aletaha D; Xu S; Han J; Baker D; St Clair EW
    Ann Rheum Dis; 2009 Oct; 68(10):1535-40. PubMed ID: 18957487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiographic changes and factors associated with subsequent progression of damage in weight-bearing joints of patients with rheumatoid arthritis under TNF-blocking therapies-three-year observational study.
    Matsushita I; Motomura H; Seki E; Kimura T
    Mod Rheumatol; 2017 Jul; 27(4):570-575. PubMed ID: 27589926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis.
    Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Kerstens PJ; Nielen MM; Vos K; van Schaardenburg D; Speyer I; Seys PE; Breedveld FC; Allaart CF; Dijkmans BA
    Ann Rheum Dis; 2010 Jan; 69(1):65-9. PubMed ID: 19155234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study.
    van der Heijde D; Durez P; Schett G; Naredo E; Østergaard M; Meszaros G; De Leonardis F; de la Torre I; López-Romero P; Schlichting D; Nantz E; Fleischmann R
    Clin Rheumatol; 2018 Sep; 37(9):2381-2390. PubMed ID: 30078086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
    Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN;
    N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of joint structure in patients with rheumatoid arthritis].
    Tanaka Y
    Clin Calcium; 2013 Mar; 23(3):409-17. PubMed ID: 23445895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
    Suzuki Y; Wakabayashi T; Saito E; Suwa A
    Clin Calcium; 2007 Apr; 17(4):546-52. PubMed ID: 17404484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DC-ART: preventing or significantly decreasing the rate of progression of structural joint damage.
    Scott DL; Adebajo AO; el Badaway S; Kirwan J; van de Putte LB; van Riel PL
    J Rheumatol Suppl; 1994 Sep; 41():36-40. PubMed ID: 7799383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Early recognition of rheumatoid arthritis].
    van der Helm-van Mil AH; Posthumus MD
    Ned Tijdschr Geneeskd; 2011; 155(30-31):A2902. PubMed ID: 22085506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasonographic predictors for the development of joint damage in rheumatoid arthritis patients: a single joint prospective study.
    Macchioni P; Magnani M; Mulè R; Galletti S; Catanoso M; Pignotti E; Boiardi L; Meliconi R; Salvarani C
    Clin Exp Rheumatol; 2013; 31(1):8-17. PubMed ID: 22935203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective Follow-Up of Cortical Interruptions, Bone Density, and Micro-structure Detected on HR-pQCT: A Study in Patients with Rheumatoid Arthritis and Healthy Subjects.
    Peters M; van den Bergh JP; Geusens P; Scharmga A; Loeffen D; Weijers R; van Rietbergen B; van Tubergen A
    Calcif Tissue Int; 2019 Jun; 104(6):571-581. PubMed ID: 30707271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treat-to-target: a tailored treatment approach to rheumatoid arthritis.
    Palmer D; El Mledany Y
    Br J Nurs; 2013 Mar 28-Apr 10; 22(6):308, 310, 312-8. PubMed ID: 23901448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients.
    Aletaha D; Alasti F; Smolen JS
    Ann Rheum Dis; 2013 Jan; 72(1):7-12. PubMed ID: 22915619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key randomized trials of single agents in early rheumatoid arthritis.
    van de Putte LB
    J Rheumatol Suppl; 2002 Nov; 66():13-9. PubMed ID: 12435164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis.
    van der Heide A; Remme CA; Hofman DM; Jacobs JW; Bijlsma JW
    Arthritis Rheum; 1995 Oct; 38(10):1466-74. PubMed ID: 7575696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes.
    Paulshus Sundlisæter N; Aga AB; Olsen IC; Hammer HB; Uhlig T; van der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA;
    Ann Rheum Dis; 2018 Oct; 77(10):1421-1425. PubMed ID: 29934373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.
    Archer R; Hock E; Hamilton J; Stevens J; Essat M; Poku E; Clowes M; Pandor A; Stevenson M
    Health Technol Assess; 2018 Nov; 22(66):1-294. PubMed ID: 30501821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis.
    Taylor PC; Keystone EC; van der Heijde D; Weinblatt ME; Del Carmen Morales L; Reyes Gonzaga J; Yakushin S; Ishii T; Emoto K; Beattie S; Arora V; Gaich C; Rooney T; Schlichting D; Macias WL; de Bono S; Tanaka Y
    N Engl J Med; 2017 Feb; 376(7):652-662. PubMed ID: 28199814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should we redefine treatment targets in rheumatoid arthritis? Low disease activity is sufficiently strict for patients who are anticitrullinated protein antibody-negative.
    de Punder YM; Hendrikx J; den Broeder AA; Valls Pascual E; van Riel PL; Fransen J
    J Rheumatol; 2013 Aug; 40(8):1268-74. PubMed ID: 23729803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.